The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Valproic Acid‐Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms
Abstract
Abstract:Administration of the antiepileptic drug valproic acid (VPA) during early pregnancy can result in a 1–2. incidence of spina bifida aperta, a closure defect of the posterior neural tube in the human. The predominant defect produced by VPA in the mouse is exencephaly, a closure defect of the anterior neural tube. Recent experiments demonstrate that an appropriate dosing regimen (consecutive doses of VPA on day 9 of gestation) can also result in a low incidence of spina bifida aperta, and a high incidence of spina bifida occulta in the mouse as a potential animal model. Relatively high doses and concentrations of VPA are needed in the mouse to produce neural tube defects, the human appears to be more sensitive in this regard. Maximal concentrations and not AUC (area under the concentration‐time curve) values correlate with the incidence of neural tube defects in the mouse which could in part be explained by saturation of plasma protein binding, increased free drug available for placental transfer and the embryonic neuroepithelium acting as a “deep compartment”. It is likely that the parent drug and not a metabolite is the proximate teratogen. Structure‐activity relationships show a strict structural requirement for high teratogenic potency: the molecule must contain an α‐hydrogen atom, a carboxyl function, branching on carbon atom 2 with two chains containing 3 carbon atoms each for maximum activity. If these two carbon chains are different, then enantiomers are present such as the R‐ and S‐enantiomers of 2‐n‐propyl‐4‐pentenoic acid (4‐en‐VPA), 2‐n‐propyl‐4‐pentynoic acid (4‐yn‐VPA) and 2‐ethylhexanoic acid. These enantiomers were synthesized and shown to be significantly different in regard to teratogenic potency. Pharmacokinetic studies indicate that both enantiomers of each compound reach the embryo to the same degree. Therefore, the intrinsic teratogenic activity of the enantiomers differ, suggesting a stereoselective interaction between the drugs and a chiral structure within the embryo, is involved in the mechanism of action. In sharp contrast to the teratogenic effect, the anticonvulsant activity and neurotoxicity of this compound class show broad structural specificity, opening the possibility for development of novel antiepileptic agents with low teratogenic potency such as 2‐n‐propyl‐2‐pentenoic acid (2‐en‐VPA). The molecular mechanism of the teratogenicity of VPA is quite unknown; of the several hypothesis suggested, the interaction of VPA with embryonic folate metabolism is discussed here.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Laurence, K. M., James, N., Miller, M. H., Tennant, G. B., & Campbell, H. (1981) · BMJ · doi:10.1136/bmj.282.6275.1509 · Cited by 684
MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS
Robert, E., & Guibaud, P. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90908-4 · Cited by 539
Valproic acid hepatic fatalities: A retrospective review
Dreifuss, F. E., Santilli, N., Langer, D. H., Sweeney, K. P., Moline, K. A., & Menander, K. B. (1987) · Neurology · doi:10.1212/wnl.37.3.379 · Cited by 483
DiLiberti, J. H., Farndon, P. A., Dennis, N. R., & Curry, C. J. R. (1984) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320190308 · Cited by 399
Mechanisms of neurulation: traditional viewpoint and recent advances
Schoenwolf, G. C., & Smith, J. L. (1990) · Development · doi:10.1242/dev.109.2.243 · Cited by 389
The embryonic development of mammalian neural tube defects
Copp, A. J., Brook, F. A., Peter Estibeiro, J., Shum, A. S. W., & Cockroft, D. L. (1990) · Progress in Neurobiology · doi:10.1016/0301-0082(90)90037-h · Cited by 336
Verification of the fetal valproate syndrome phenotype
Ardinger, H. H., Atkin, J. F., Blackston, R. D., Elsas, L. J., Clarren, S. K., Livingstone, S., Flannery, D. B., Pellock, J. M., Harrod, M. J., Lammer, E. J., et al. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320290123 · Cited by 302
IN-UTERO EXPOSURE TO VALPROATE AND NEURAL TUBE DEFECTS
Lindhout, D., & Schmidt, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91711-3 · Cited by 299
Neural-Tube Defects and Derangement of Homocysteine Metabolism
(1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240315 · Cited by 285
Jäger-Roman, E., Deichl, A., Jakob, S., Hartmann, A.-M., Koch, S., Rating, D., Steldinger, R., Nau, H., & Helge, H. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80949-0 · Cited by 282
Self-citation
Cited by
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
Botto, L. D., Moore, C. A., Khoury, M. J., & Erickson, J. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911113412006 · Cited by 980
The valproic acid-induced rodent model of autism
Nicolini, C., & Fahnestock, M. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.017 · Cited by 592
Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action
Löscher, W. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00075-6 · Cited by 532
Metadata
- Authors
- Nau, H., Hauck, R., & Ehlers, K.
- Venue
- Pharmacology & Toxicology
- Publisher
- Wiley
- Published
- 1991-11
- Volume
- 69
- Issue
- 5
- Pages
- 310-321
- ISSN
- 0901-9928 (ISSN-L)
- OpenAlex
- W2047732548
- Cited by
- 297
- References
- 44
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Valproic Acid‐Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms. https://app.cochat.ai/papers/10.1111/j.1600-0773.1991.tb01303.x
- The paper
- Nau, H., Hauck, R., & Ehlers, K. (1991). Valproic Acid‐Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms. Pharmacology & Toxicology. https://doi.org/10.1111/j.1600-0773.1991.tb01303.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.